Primus In News
Can injections be needle-free, painless? This Pune-based firm has the answer
05-06-2025
Nilaya Varma, Group CEO & Co-Founder, Primus Partners, highlights that innovations in drug delivery systems are driving the growth of needle-free injectors. With increasing concerns over needle-stick injuries, rising chronic diseases, and the growing demand for mass vaccinations and home care, the global needle-free injector market—valued at $1.3 billion in 2022—is projected to grow at a CAGR of 7.8%, with strong potential in both global and Indian markets.
Explore Related Insights
- Reinventing Retail: How local kirana stores are adapting to India’s quick commerce boom
- Ethanol From Grains May Generate Rs 35,000 Crore In Earnings For Farmers
- Travellers shifting to offline mode after GST on non-AC bus rides
- Empty courtyards, fading voices: Elderly isolation amid migration exposed in report
